These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1278662)

  • 1. [Investigation of HL-antigens in cervical cancer patients (author's transl)].
    Koenig UD; Müller N
    Geburtshilfe Frauenheilkd; 1976 May; 36(5):416-20. PubMed ID: 1278662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HL-A polymorphism and its relation to cervix neoplasms].
    Koenig UD; Müller N
    Fortschr Med; 1977 Mar; 95(9):565-8. PubMed ID: 844783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
    Dostal V; Mayr WR
    Osterr Z Onkol; 1977; 3(5-6):119-21. PubMed ID: 193077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL; Rogentine GN; Chretien PB
    Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histocompatibility antigens (HL-A) in psoriasis. A study of 104 unrelated patients (author's transl)].
    Schoefinius HH; Braun-Falco O; Scholz S; Steinbauer-Rosenthal I; Wank R; Albert ED
    Dtsch Med Wochenschr; 1974 Mar; 99(10):440-4. PubMed ID: 4471830
    [No Abstract]   [Full Text] [Related]  

  • 6. HL-A antigens in solid tumors.
    Takasugi M; Terasaki PI; Henderson B; Mickey MR; Menck H; Thompson RW
    Cancer Res; 1973 Apr; 33(4):648-50. PubMed ID: 4739655
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frequencies of hl-a phenotypes, genes, and haplotypes in the viennese population (author's transl)].
    Mayr WR
    Wien Klin Wochenschr; 1975 Aug; 87(15):488-92. PubMed ID: 1226756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pemphigus vulgaris and HL-A antigens (author's transl)].
    Hashimoto K; Miki Y; Nakata S; Shirakura R; Mori T
    Nihon Hifuka Gakkai Zasshi; 1975 Oct; 85(11):635-7. PubMed ID: 1240508
    [No Abstract]   [Full Text] [Related]  

  • 9. Major histocompatibility complex class II polymorphisms and risk of cervical cancer in Puerto Rican women.
    Climent C; Nazario CM; Umpierre S; Quintero M; Gorbea S
    P R Health Sci J; 2007 Jun; 26(2):97-101. PubMed ID: 17722421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in Finland.
    Castro FA; Haimila K; Pasanen K; Kaasila M; Patama T; Partanen J; Surcel HM; Pukkala E; Lehtinen M
    Int J STD AIDS; 2007 Oct; 18(10):672-9. PubMed ID: 17945045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
    Apple RJ; Erlich HA; Klitz W; Manos MM; Becker TM; Wheeler CM
    Nat Genet; 1994 Feb; 6(2):157-62. PubMed ID: 8162070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on LMIT of cervical cancer (author's transl)].
    Yamamoto H
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1917-26. PubMed ID: 7211210
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Hiserodt JC; Pecorelli S; Parham GP
    Gynecol Oncol; 1998 Aug; 70(2):195-201. PubMed ID: 9740690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HL-A antigens in carcinoma of the breast, ovarium, cervix and endometrium: possible association of haplotype HL-A10-W18 with carcinoma of the breast.
    Bertrams J; Thraenhart O; Feldmann U; Kuwert E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975; 83(3):219-22. PubMed ID: 125012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on HL-A system of the Japanses population. New Japanese-specific HL-A antigens--SN-1 and SN-2 (author's transl)].
    Saito S
    Fukuoka Igaku Zasshi; 1975 Jun; 66(6):429-44. PubMed ID: 1171815
    [No Abstract]   [Full Text] [Related]  

  • 18. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
    Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
    Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
    J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.